SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-223996
Filing Date
2006-11-06
Accepted
2006-11-03 19:24:38
Documents
11
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 568552
2 AMENDED AND RESTATED COLLABORATION AGREEMENT dex102.htm EX-10.2 812984
3 SIXTH AMENDMENT AGREEMENT dex103.htm EX-10.3 73189
4 FORM OF RESTRICTED STOCK AWARD AGREEMENT dex104.htm EX-10.4 17662
5 DEVELOPMENT AND LICENSE AGREEMENT dex105.htm EX-10.5 224871
6 AGREEMENT AND PLAN OF MERGER dex106.htm EX-10.6 462496
7 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 7964
8 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 8007
9 CERTIFICATION OF CEO AND CFO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex32.htm EX-32 3257
10 GRAPHIC g58397img100.jpg GRAPHIC 18607
11 GRAPHIC g58397img200.jpg GRAPHIC 12025
  Complete submission text file 0001193125-06-223996.txt   2222883
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 061188336
SIC: 2836 Biological Products, (No Diagnostic Substances)